by in
Entry Author Date Location
Constellation Pharma Raises More Money and Further Defines Pipeline 06/17/11 Boston
Vertex CF Drug Delivers, Follica Patent Application Reveals Tech, RXi Buys Apthera, & More Boston-Area Life Sciences News 04/01/11 Boston
Epizyme, Riding High on Two Big Pharma Deals, Zeroes in on Personalized Cancer Therapy 03/29/11 Boston
World Energy Backs Retroficiency, American Superconductor Gets Finnish Firm, BuyWithMe Buys LocalTwist, & More Boston-Area Deals News 03/16/11 Boston
Epizyme Nabs Eisai Deal, Termeer Could Make $221.2M From Genzyme Buyout, Gates Funds Nimbus, & More Boston-Area Life Sciences News 03/11/11 Boston
Epizyme Takes $6M Upfront in Cancer Drug Deal with Eisai 03/10/11 Boston
$12.7M Blows in for Wind Power Holdings, Epizyme Forges Alliance with GlaxoSmithKline, & Many More Boston-Area Deals 01/12/11 Boston
Epizyme Nabs $650M Deal With Glaxo To Hunt for Epigenetic Drugs 01/10/11 Boston
MIT Cancer Research Star Tyler Jacks Takes Closing Keynote Role at Xconomy Forum 09/28/10 Boston
Syndax Pharma Seeks to Reprogram Tumor Cells to Treat Breast Cancer 06/08/10 Boston
Glaxo’s SR One Injects Pharma Bucks into $22M Round for Constellation Pharma 06/02/10 Boston
Biogen Idec Reaches Deal With Icahn, Ironwood CEO Shares IPO Strategy, Luke Maps out the Genetics Institute Diaspora, & More Boston-Area Life Sciences News 03/26/10 Boston
Epizyme Entices Broad Institute Player, Robert Gould, to Take Over as CEO 03/24/10 Boston
2009′s Top 10 Private Equity Deals in Massachusetts: The List 01/25/10 Boston
5AM Gathers $200M Fund, Advanced Cell Technology Advances with $2.8 Million, Gloucester Picked up for $640M, & More Boston-Area Deals News 12/11/09 Boston
Epizyme Tacks On Extra $8M Financing For Drugs that Turn Genes On or Off 12/08/09 Boston
Epizyme Obtains $8,000,000 Series B Financing 12/08/09 Boston
Massachusetts Startup Funding Slowed Way Down in October—But Early Stage Deals Gained 11/12/09 Boston
Top 10 (+ 1) New England Venture Deals of Q3 2009 10/20/09 Boston
Epizyme Grabs $32M, A123 Systems’ IPO Enriches BU, & More Boston-Area Deals News 10/12/09 Boston
Public Biotechs’ Finances Foundering, Epizyme Banks $32M, Paratek Cuts Deal with Novartis, & More Boston-Area Life Sciences News 10/09/09 Boston
Epizyme Snags $32M Round to Make Drugs Against Cancer and More 10/07/09 Boston
Pickett to Relinquish Biogen Idec Board Seat, New Financing for iWalk, Genocea Goes After Vaccine Market, & More Boston-Area Life Sciences News 09/02/09 Boston
New Constellation Pharma CEO Gives Expected Timeline for Epigenetics Firm’s Cancer Drug Research 09/01/09 Boston
Constellation Pharma Hires New CEO, Collects Last $17M of its Series A Financing 08/13/09 Boston
Infinity Halts Trial of Lead Cancer Drug, Tysabri Sales Short of Projections, Myomo Slashes Staff, & More Boston-Area Life Sciences News 04/22/09 Boston
Epizyme Unveils Technology, Targeting Cancer with Epigenetic Drugs 04/20/09 Boston
MPM Capital, World’s Biggest Healthcare VC Fund, Balances Startups With Stocks 10/07/08 Boston
Link Makes $40M Connection, Concert and Indevus Launch Clinicals, Genzyme’s Big Cholesterol Strategy, & More Boston-Area Life Sciences News 10/01/08 Boston
With Backing From MPM and Kleiner Perkins, EpiZyme Aims to Turn Genes On and Off 09/26/08 Boston
Page 3 of 3 « previous page